Cargando…
Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy
Leprosy is a complex infectious disease caused by Mycobacterium leprae that is a leading cause of nontraumatic peripheral neuropathy. Current control strategies, with a goal of early diagnosis and treatment in the form of multidrug therapy, have maintained new case reports at ~225,000 per year. Diag...
Autores principales: | Duthie, Malcolm S, Balagon, Marivic F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854245/ https://www.ncbi.nlm.nih.gov/pubmed/27175099 http://dx.doi.org/10.2147/RMHP.S76058 |
Ejemplares similares
-
The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study)
por: Richardus, Renate A, et al.
Publicado: (2013) -
A Retrospective Study of the Epidemiology of Leprosy in Cebu: An Eleven-Year Profile
por: Scheelbeek, Pauline F. D., et al.
Publicado: (2013) -
Serum Metabolomics Reveals Higher Levels of Polyunsaturated Fatty Acids in Lepromatous Leprosy: Potential Markers for Susceptibility and Pathogenesis
por: Al-Mubarak, Reem, et al.
Publicado: (2011) -
An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++
por: Mieras, Liesbeth F, et al.
Publicado: (2018) -
AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)